J(
Jatinder (Jay) Dhaliwal
Chief Executive Officer, Interim Chief Financial Officer, Director
Virpax PharmaceuticalsTherapeutic Areas
Virpax Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Probudur | Post-operative Pain | Preclinical |
| Envelta | Severe Pain | Preclinical |
| NobrXiol | Rare Pediatric Epilepsy | Preclinical |
| PES200 | Post-Traumatic Stress Disorder (PTSD) | Discovery/Preclinical |
| NES100 | Not Specified (Neuro/CNS) | Preclinical |
| Intranasal COVID Vaccine | COVID-19 Prevention | Research |
| Anti-Viral for Flu-like Viruses | Prevention of Flu-like Viruses | Early Development |